The HIFα-Stabilizing Drug Roxadustat Increases the Number of Renal Epo-Producing Sca-1(+) Cells

Inhibition of the prolyl-4-hydroxylase domain (PHD) enzymes, leading to the stabilization of hypoxia-inducible factor (HIF) α as well as to the stimulation of erythropoietin (Epo) synthesis, is the functional mechanism of the new anti-anemia drug roxadustat. Little is known about the effects of roxa...

Descripción completa

Detalles Bibliográficos
Autores principales: Jatho, Aline, Zieseniss, Anke, Brechtel-Curth, Katja, Guo, Jia, Böker, Kai Oliver, Salinas, Gabriela, Wenger, Roland H., Katschinski, Dörthe M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869801/
https://www.ncbi.nlm.nih.gov/pubmed/35203399
http://dx.doi.org/10.3390/cells11040753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869801/
https://www.ncbi.nlm.nih.gov/pubmed/35203399
http://dx.doi.org/10.3390/cells11040753

Ejemplares similares